MedTrace Logo

Assessment of Circulatory Compromise With Ox-Imager Using a Vascular Occlusion Test Protocol

NCT03563105 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-06-20

No results posted yet for this study

Summary

The objective of this study is to evaluate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system to measure potential circulatory compromise.

Conditions

  • Circulatory; Change

Interventions

DEVICE

The Ox-Imager Mini (Desaturation)

Vascular Occlusion Test

Sponsors & Collaborators

  • Modulated Imaging Inc.

    lead INDUSTRY

Principal Investigators

  • Amaan Mazhar, PhD · Modulated Imaging Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-30
Primary Completion
2019-05-01
Completion
2019-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03563105 on ClinicalTrials.gov